The GSN Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for targeted disruption of the human GSN gene in the near-haploid HAP1 cell line. This product provides a heterogeneous pool of cells carrying diverse loss-of-function edits, enabling functional studies of gelsolin without the confounding effects of clonal variation. The polyclonal format is particularly suited for experiments requiring population-level phenotypic analysis, circumventing the limitations of single-cell-derived knockout clones. By utilizing CRISPR/Cas9-mediated gene disruption, these cells serve as a versatile loss-of-function model for investigating gelsolin-dependent processes in a leukemic background.
The host HAP1 cell line is a near-haploid, male human cell line derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype simplifies genetic manipulation and facilitates straightforward genotype?Cphenotype correlation, making it a valuable tool for functional genomics and drug target validation. Originating from a leukemic progenitor, HAP1 retains signaling pathways relevant to hematopoietic malignancies, while its adherent growth and stable doubling time support reproducible cell-based assays. These characteristics collectively position HAP1 as a robust platform for studying genes involved in cancer biology and cytoskeletal regulation.
Gelsolin, encoded by GSN, is a calcium-activated actin-binding protein that severs and caps actin filaments, thereby controlling cytoskeletal reorganization, cell morphology, and motility. Its activity is intimately regulated by upstream signals, including caspase-3 cleavage during apoptosis, phosphatidylinositol 4,5-bisphosphate (PIP2) binding at the plasma membrane, and phosphorylation by Akt kinase. Gelsolin directly interacts with actin monomers and filaments, tropomyosin, and vinculin, integrating mechanical and signaling cues to modulate actin dynamics. Downstream, gelsolin-mediated severing promotes actin filament turnover, while its capping activity influences cell shape, adhesion, and apoptotic cell rounding. Within the PI3K/Akt pathway, gelsolin serves as a critical effector linking growth factor signaling to cytoskeletal responses.
In HAP1 cells, gelsolin knockout abolishes calcium-dependent actin severing and capping, leading to impaired actin remodeling. This disruption manifests as defective cell migration, altered adhesion dynamics, and attenuated apoptosis, reflecting the multifaceted roles of gelsolin in normal and malignant cells. The haploid nature of HAP1 ensures that even heterozygous edits can produce quantifiable phenotypes, enhancing the sensitivity of functional assays. Consequently, this polyclonal knockout model is especially relevant for dissecting gelsolin??s contributions to leukemic cell invasiveness and drug-induced apoptosis, providing a genetically tractable system that parallels key aspects of cancer metastasis.
Researchers can employ this cell model in a wide range of applications, from basic cytoskeletal biology to translational oncology. Typical assays include Western blotting to confirm gelsolin ablation, immunofluorescence staining to visualize actin cytoskeleton defects, wound healing and Transwell migration assays to assess motility changes, and caspase activation assays to quantify apoptotic responses. The polyclonal population is also well-suited for high-throughput drug screening aimed at identifying compounds that modulate gelsolin-related pathways or compensate for its loss. For additional information, technical support, or custom inquiries, please contact Ascent Research.
